Dec
Nexavar First FDA-Approved Drug Therapy for Liver
Cancer
Change in Liver Transplant Criteria Reduced Waiting
List Deaths
Prophylaxis with Pegylated Interferon Alfa-2a (Pegasys)
plus Ribavirin vs No Prophylaxis after Liver Transplantation
Invention Offers Sick Livers a Well-Needed Rest
HCV Treatment Aided by New Platelet-Boosting Drug
Nov
From The : 58th Annual Nov 2007 AASLD Meeting
Liver Transplantation:
Information on
allocation of livers, recurrent HCV after transplantation, treatment of HCV
before and after liver transplantation, post transplantation disease
progression, and long term outcomes after liver transplantation
Imaging May Help Diagnose Hepatic Encephalopathy
Insulin Resistance and
Diabetes
Propranolol Better First-Line Prophylaxis Than
Ligation for Variceal Bleeding
Researching Cure For Liver Cirrhosis
Minimal Hepatic Encephalopathy Associated With
Increased Traffic Accidents
Propranolol Better First-Line Prophylaxis
Than Ligation for Variceal Bleeding
Continue reading "The First Liver Transplant to Erase
Hepatitis C"
Driving With Minimal Hepatic Encephalopathy:
Real World Consequences?
Symptoms of Liver Disease & Risk
Factors for Upper GI Bleeding
Prevention of Variceal Bleeding in Candidates Awaiting
Liver Transplantation
Outcomes after Liver Re-transplantation in Patients
with Recurrent Chronic Hepatitis C
The Use of Transient Elastometry for
Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus
Coinfection: only detects cirrhosis
Coffee Consumption May Reduce the Risk of Liver Cancer
Sodium Levels Can Help Predict Outcomes before
and after Liver Transplantation
Bishop of Athens to Undergo Liver Transplant
Rare Liver Transplant with Child is Successful
DDW 2007 Highlights:
Part 2
Calderdale liver disease warning
Liver transplants one step closer
Strategies for the Management of
Hepatocellular Carcinoma
Treatment of Recurrent Hepatitis C in Liver
Transplant Recipients
Natural History of Hepatitis C in Patients with Severe
Liver Fibrosis
Three Studies Assess Consensus Interferon for
Hepatitis C in Prior Non-responders, Relapsers and Patients with a High
Likelihood of Treatment Failure
Hepatitis C Treatment in Liver Transplant
Recipients
'Virtual Patient' To Simulate Real-time Organ
Motions For Radiation Therapy
New acute liver failure research from
University of Texas, Department of Internal Medicine outlined
Special Hepatic Issues and Populations:
Expert Analysis From EASL
International Registry Planned for Live Donor
Transplant Outcomes
Clinical course of hepatitis C virus infection in
renal transplant recipients.
DDW: Hepatitis C Patients Benefit with New Livers
from HCV ...
HCV patients survival after liver transplantation is not
improving
recipients.Pegylated Interferon/ribavirin Therapy Results in Low
SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients
Sustained Virological Response Improves Fibrosis
Progression and Reduces Mortality after Liver Transplantation
Sustained Response to Interferon Monotherapy Reduces
Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis
Interferon Gamma Does Not Reverse Fibrosis in
Hepatitis C Patients with Advanced Liver Disease
Heavy Alcohol Use Worsens Disease Progression in Women
with Chronic Hepatitis C
Liver Transplantation for Hepatitis C Patients
Improving Quality Of Life For Patients With
Cirrhosis
Most Americans Don't Understand Acetaminophen
Dangers
Older donor allografts are associated with
poor patient survival after living do
Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic
Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis
Trial (HALT-C Study)
Liver transplant: Treating end-stage liver disease
Scarce influence of corticosteroid boluses on
long-term viral load and liver histology in transplanted patients
with recurrent hepatitis C.
Recurrent disease after liver transplantation. A
therapeutic dilemma or treatable?
Selective Use of Older Adults in Right Lobe Living
Donor Liver Transplantation
Nontransplantation of Livers from Deceased Donors Who
Are Able to Donate Another
Clinical and histological efficacy of pegylated
interferon and ribavirin therapy of recurrent hepatitis C after liver
transplantation.
2008
2007
2006
2005
Research Archives
2004-2002
(Back to main transplant page)
|
